The Renaissance IPO Index has had a positive start to the third quarter, and this week reached its highest level since April 2022.Prior to yesterday’s sell-off, markets rallied from the past week as a cool inflation report and positive comments from the...read more
Soon after families carve up the Thanksgiving turkey, the US IPO market will see its own large carve-outs.Spin-offs have been a recurring theme over the past couple years, and recent filings from ZEEKR (ZK) and UL Solutions (ULS) signal that the trend is...read more
In what would be the largest US IPO since late 2021, Kenvue (KVUE) is slated to raise $3.3 billion, more than doubling YTD IPO proceeds. It's scheduled to begin trading this week. Being spun out of Johnson & Johnson, consumer health giant Kenvue is...read more
The IPO Market Flips from Boom to Bust in 2022After the prior year’s record activity, the 2022 US IPO market ground to a halt as the war in Ukraine, a valuation correction in high-multiple stocks, historic interest rate hikes, and looming fears of a...read more
The IPO Index reached a two-year high this week. Here are the biggest winners.
The Renaissance IPO Index has had a positive start to the third quarter, and this week reached its highest level since April 2022.Prior to yesterday’s sell-off, markets rallied from the past week as a cool inflation report and positive comments from the...read more
IPO investors crave carve-outs with 2 more teed up after Thanksgiving
Soon after families carve up the Thanksgiving turkey, the US IPO market will see its own large carve-outs.Spin-offs have been a recurring theme over the past couple years, and recent filings from ZEEKR (ZK) and UL Solutions (ULS) signal that the trend is...read more
Kenvue is the IPO market's latest spin-off; here's how past spin-offs have performed alongside former parents
In what would be the largest US IPO since late 2021, Kenvue (KVUE) is slated to raise $3.3 billion, more than doubling YTD IPO proceeds. It's scheduled to begin trading this week. Being spun out of Johnson & Johnson, consumer health giant Kenvue is...read more
Updated: Renaissance Capital's 2022 US IPO Market Review
The IPO Market Flips from Boom to Bust in 2022After the prior year’s record activity, the 2022 US IPO market ground to a halt as the war in Ukraine, a valuation correction in high-multiple stocks, historic interest rate hikes, and looming fears of a...read more